Provided by Tiger Trade Technology Pte. Ltd.

HENGRUI PHARMA

46.460
-1.740-3.61%
Volume:12.04M
Turnover:568.78M
Market Cap:308.36B
PE:33.78
High:49.000
Open:48.300
Low:46.040
Close:48.200
52wk High:94.869
52wk Low:46.040
Shares:6.64B
HK Float Shares:258.00M
Volume Ratio:1.19
T/O Rate:4.67%
Dividend:0.23
Dividend Rate:0.50%
EPS(LYR):1.375
ROE:12.46%
ROA:7.02%
PB:4.10
PE(LYR):33.78
PS:8.45

Loading ...

Are "Old Economy" Stocks Signaling a Market Shift?

Deep News
·
Jul 06

AH Share Premium and Deviation Data for July 6th

Stock News
·
Jul 06

Movement Alert|Hengrui Pharma Rises 4.01% in Regular Trading, Pharmaceutical Sector Rallies Amid Multiple Drug Approval Catalysts

Market Focus
·
Jul 06

AH Share Premium and Deviation Rankings for July 3rd

Stock News
·
Jul 03

Movement Alert|Hengrui Pharma Rises 3.2% in Regular Trading, Multiple New Drug Approvals and Priority Review Catalyze Gains

Market Focus
·
Jul 03

Hengrui Pharma Gets Nod to Trial Drug Combination for Hepatocellular Carcinoma

MT Newswires Live
·
Jul 03

Hengrui Pharma Reports Cumulative Share Buyback Totaling 13.47 Million A-Shares as of June 30

Stock News
·
Jul 02

Hengrui Pharma Gains Regulatory Nod for Clinical Trials of Three Drug Candidates

Stock News
·
Jul 02

HENGRUI PHARMA Keeps H-Share Capital Steady, Ups A-Share Treasury Stock via RMB 66.1 Million Buy-back in June

Bulletin Express
·
Jul 02

Hengrui Pharma Shares Surge Over 6% on New Drug Indication Approval and International Expansion Success

Stock News
·
Jul 02

Movement Alert|Hengrui Pharma Rises 3.72% in Regular Trading, Pharmaceutical Sector Rally and Multiple Drug Approvals Drive Gains

Market Focus
·
Jul 02

AH Share Premium and Deviation Rankings as of July 1st Close

Stock News
·
Jul 01

AH Share Premium and Deviation Rankings as of June 30th Close

Stock News
·
Jun 30

AH Share Premium and Deviation Data for June 29th

Stock News
·
Jun 29

Movement Alert|Hengrui Pharma Rises 3.02% in Regular Trading, Pharma Sector Rallies as Multiple Regulatory Milestones Boost Sentiment

Market Focus
·
Jun 29

AH Share Premium and Deviation Rankings for June 26

Stock News
·
Jun 26

Hengrui Pharma Gets Nod to Trial HRS-4508 Tablets As Advanced Tumor Treatment; Shares Down 4%

MT Newswires Live
·
Jun 26

Hengrui Pharmaceuticals Unit Wins China Approval to Expand Indication of Cancer Drug

MT Newswires Live
·
Jun 26

Movement Alert|Hengrui Pharmaceuticals Falls 3.53% in Regular Trading, Trading at 54.15 HKD

Market Focus
·
Jun 26

Hengrui Pharmaceuticals Unit Wins China Marketing Approval for Dry Eye Drug

MT Newswires Live
·
Jun 26